142 related articles for article (PubMed ID: 720789)
21. [Letter: Heart death and oral antidiabetics].
de Nobel E; van 't Laar A
Ned Tijdschr Geneeskd; 1975 Nov; 119(44):1732-3. PubMed ID: 1214881
[No Abstract] [Full Text] [Related]
22. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
23. Oral hypoglycaemics in diabetes mellitus.
Lancet; 1975 Sep; 2(7933):489-91. PubMed ID: 51292
[No Abstract] [Full Text] [Related]
24. The FDA and hypoglycemic drugs.
Davidson JK
JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
[No Abstract] [Full Text] [Related]
25. Farewell to phenformin for treating diabetes mellitus.
Williams RH; Palmer JP
Ann Intern Med; 1975 Oct; 83(4):567-8. PubMed ID: 1166991
[No Abstract] [Full Text] [Related]
26. The UGDP--tolbutamide and mortality.
Knowles HC
Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
[No Abstract] [Full Text] [Related]
27. [Oral antidiabetic drugs].
Z Allgemeinmed; 1975 Feb; 51(5):235. PubMed ID: 1130116
[No Abstract] [Full Text] [Related]
28. [Letter: Oral antidiabetics and cardiovascular disorders].
Ned Tijdschr Geneeskd; 1975 Nov; 119(44):1731-2. PubMed ID: 1214880
[No Abstract] [Full Text] [Related]
29. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Goetz FC
Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
[No Abstract] [Full Text] [Related]
30. [Evaluation of oral hypoglycemic agents following the University Group of Diabetes Program].
Sasaki A
Nihon Rinsho; 1977 Feb; 35(2):317-23. PubMed ID: 558370
[No Abstract] [Full Text] [Related]
31. Misunderstanding or error? The UGDP report after four years.
Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G
Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992
[No Abstract] [Full Text] [Related]
32. The Achilles heel of the University Group Diabetes Program.
Kilo C; Miller JP; Williamson JR
JAMA; 1980 Feb; 243(5):450-7. PubMed ID: 6985989
[TBL] [Abstract][Full Text] [Related]
33. The UGDP controversy. Clinical trials versus clinical impressions.
Prout TE; Knatterud GL; Meinert CL; Klimt CR
Diabetes; 1972 Oct; 21(10):1035-40. PubMed ID: 4561330
[No Abstract] [Full Text] [Related]
34. Controversy over study of diabetes drugs continues for nearly a decade.
Kolata GB
Science; 1979 Mar; 203(4384):986-90. PubMed ID: 370980
[No Abstract] [Full Text] [Related]
35. [Attack after oral antidiabetics].
Frey H
Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2097-8. PubMed ID: 5479224
[No Abstract] [Full Text] [Related]
36. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
Seltzer HS
Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
[No Abstract] [Full Text] [Related]
37. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
Teuscher A
Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
[No Abstract] [Full Text] [Related]
38. Controlled clinical trials and the tolbutamide controversy.
Lavietes PH
Conn Med; 1971 Apr; 35(4):271-2. PubMed ID: 4927818
[No Abstract] [Full Text] [Related]
39. Therapeutics: recent suggestions for the treatment of hypothyroidism and diabetes mellitus.
Block MB
Ariz Med; 1975 Apr; 32(4):344-6. PubMed ID: 1119957
[No Abstract] [Full Text] [Related]
40. Oral anti-diabetic agents: how do they stand after the university group diabetes program (UGDP)?
Drug Ther Bull; 1977 May; 15(10):37-9. PubMed ID: 326507
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
